Rituximab for rheumatoid arthritis

  • Protocol
  • Intervention

Authors

  • Maria Angeles Lopez-Olivo,

    1. The University of Texas, M.D. Anderson Cancer Center, General Internal Medicine, Ambulatory Treatment and Emergency Care, Houston, Texas, USA
    Search for more papers by this author
  • Matxalen Amezaga,

    1. The University of Texas, M.D. Anderson Cancer Center, General Internal Medicine, Ambulatory Treatment and Emergency Care, Houston, Texas, USA
    Search for more papers by this author
  • Lynda McGahan,

    1. Canadian Agency for Drugs and Technologies in Health (CADTH), HTA Directorate, Ottawa, Ontario, Canada
    Search for more papers by this author
  • Maria E Suarez-Almazor

    Corresponding author
    1. The University of Texas, M.D. Anderson Cancer Center, General Internal Medicine, Ambulatory Treatment and Emergency Care, Houston, Texas, USA
    • Maria E Suarez-Almazor, General Internal Medicine, Ambulatory Treatment and Emergency Care, The University of Texas, M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 437, Houston, Texas, 77030, USA. msalmazor@mdanderson.org.

    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the efficacy and safety of rituximab for the treatment of RA.

Ancillary